SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-118247
Filing Date
2024-04-26
Accepted
2024-04-26 16:45:28
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d778708ddef14a.htm DEF 14A 518463
2 GRAPHIC g778708g01g01.jpg GRAPHIC 243826
3 GRAPHIC g778708g02g02.jpg GRAPHIC 163335
  Complete submission text file 0001193125-24-118247.txt   1074361
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 24884655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)